Physician
Family Medicine
Dr. David C. Kaslow, MD
|
|
Give Review
Doctor David C. Kaslow, MD works in the field of Family Medicine. He graduated from University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a top medical college. University of California San Francisco School of Medicine has a rank of 3 in research and a 3 in primary care David Kaslow is also published. He has 101 publications published. The lastest publication: "Familial eosinophilia: clinical and laboratory results on a U.S. kindred.'
Publications
- Clostridium difficile and methicillin-resistant Staphylococcus aureus: emerging concepts in vaccine development.
- Approaches to malaria vaccine development using the retrospectroscope.
- Evaluation of a plasmid DNA-based anthrax vaccine in rabbits, nonhuman primates and healthy adults.
- Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus.
- Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge.
- Vaccination with polymerase chain reaction-generated linear expression cassettes protects mice against lethal influenza A challenge.
- Biological feasibility of developing prophylactic vaccines for viral pathogens: incubation period as a critical parameter.
- Comparison of rabbit and mouse models for persistence analysis of plasmid-based vaccines.
- II. Cationic lipid-formulated plasmid DNA-based Bacillus anthracis vaccine: evaluation of plasmid DNA persistence and integration potential.
- I. Poloxamer-formulated plasmid DNA-based human cytomegalovirus vaccine: evaluation of plasmid DNA biodistribution/persistence and integration.
- CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine.
- Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of first-generat...
- The effects of varying exposure to malaria transmission on development of antimalarial antibody responses in preschool children. XVI. Asembo Bay Cohort Project.
- Development of an adenovirus-shedding assay for the detection of adenoviral vector-based vaccine and gene therapy products in clinical specimens.
- Regulation of antigen-specific immunoglobulin G subclasses in response to conserved and polymorphic Plasmodium falciparum antigens in an in vitro model.
- Aotus New World monkeys: model for studying malaria-induced anemia.
- A high malaria reinfection rate in children and young adults living under a low entomological inoculation rate in a periurban area of Bamako, Mali.
- Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in...
- Short report: differential evolution of immunoglobulin G1/G3 antibody responses to Plasmodium falciparum MSP1(19) over time in malaria-immune adult Senegalese patients.
- A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum.
- A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy m...
- A DNA-based vaccine for the prevention of human cytomegalovirus-associated diseases.
- Does infection with Human Immunodeficiency Virus affect the antibody responses to Plasmodium falciparum antigenic determinants in asymptomatic pregnant women?
- Transfection of the malaria parasite and expression of firefly luciferase.
- A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
- Familial eosinophilia: clinical and laboratory results on a U.S. kindred.
- Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper e...
- Anti-merozoite surface protein-1 19-kDa IgG in mother-infant pairs naturally exposed to Plasmodium falciparum: subclass analysis with age, exposure to asexual parasite...
- Transmission blocking antibody of the Plasmodium falciparum zygote/ookinete surface protein Pfs25 also influences sporozoite development.
- The peritrophic membrane as a barrier: its penetration by Plasmodium gallinaceum and the effect of a monoclonal antibody to ookinetes.
- Hormone-sensitive adenylate cyclase. Mutant phenotype with normally regulated beta-adrenergic receptors uncoupled with catalytic adenylate cyclase.
- Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes.
- Umbilical cord compression produces pulmonary hypertension in newborn lambs: a model to study the pathophysiology of persistent pulmonary hypertension in the newborn.
- Delta Dental Plan of New Jersey sees strong growth in electronic claims.
- More practices are filing electronic claims.
- Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein, MSP1, in blood-stage infections of naive Aotus monkeys.
- Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.
- Antibody-mediated inhibition of Aedes aegypti midgut trypsins blocks sporogonic development of Plasmodium gallinaceum.
- Production of a malaria transmission-blocking protein from recombinant yeast.
- Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1.
- Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes.
- NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.
- Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine.
- Identification and cloning of a locus of serine repeat antigen (sera)-related genes from Plasmodium vivax.
- Stage-specific processing of Pfs230, a Plasmodium falciparum transmission-blocking vaccine candidate.
- Expression and immunogenicity of the C-terminus of a major blood-stage surface protein of Plasmodium vivax, Pv200(19), secreted from Saccharomyces cerevisiae.
- A developmental defect in Plasmodium falciparum male gametogenesis.
- Sporadic urban leptospirosis.
- A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines.
- Cloning and cross-species comparison of the thrombospondin-related anonymous protein (TRAP) gene from Plasmodium knowlesi, Plasmodium vivax and Plasmodium gallinaceum.
- Transmission-blocking vaccines: uses and current status of development.
- Primary structure of a novel ookinete surface protein from Plasmodium berghei.
- Expression and serologic activity of a soluble recombinant Plasmodium vivax Duffy binding protein.
- Influence of adjuvants on murine immune responses against the C-terminal 19 kDa fragment of Plasmodium vivax merozoite surface protein-1 (MSP-1).
- Minimal variation in the Pfs28 ookinete antigen from Philippine field isolates of Plasmodium falciparum.
- Comparison of Plasmodium yoelii ookinete surface antigens with human and avian malaria parasite homologues reveals two highly conserved regions.
- Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii.
- Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmod...
- Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice.
- Plasmodium malariae infection in an asymptomatic 74-year-old Greek woman with splenomegaly.
- Plasmodium falciparum Pfs40, renamed Pf39, is localized to an intracellular membrane-bound compartment and is not sexual stage-specific.
- A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and i...
- Immunogenicity of the C-terminal 19-kDa fragment of the Plasmodium falciparum merozoite surface protein 1 (MSP1), YMSP1(19) expressed in S. cerevisiae.
- A novel glucose-6-phosphate dehydrogenase in Plasmodium falciparum: cDNA and primary protein structure.
- Strain polymorphism of Plasmodium falciparum transmission-blocking target antigen Pfs230.
- Transmission-blocking immunity against malaria and other vector-borne diseases.
- Unidirectional dominance of cytoplasmic inheritance in two genetic crosses of Plasmodium falciparum.
- Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum.
- Introducing restriction sites into double-stranded plasmid DNA.
- Pgs28 belongs to a family of epidermal growth factor-like antigens that are targets of malaria transmission-blocking antibodies.
- Cloning and expression of the gene for Plasmodium falciparum transmission-blocking target antigen, Pfs230.
- Transmission-blocking activity of a chitinase inhibitor and activation of malarial parasite chitinase by mosquito protease.
- A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains.
- DNA methylation stabilizes X chromosome inactivation in eutherians but not in marsupials: evidence for multistep maintenance of mammalian X dosage compensation.
- Incomplete X chromosome dosage compensation in chorionic villi of human placenta.
- Molecular studies of marsupial X chromosomes reveal limited sequence homology of mammalian X-linked genes.
- Comparison of factor IX methylation on human active and inactive X chromosomes: implications for X inactivation and transcription of tissue-specific genes.
- A rapid biochemical method for purifying lambda DNA from phage lysates.
- Signal sequence and DNA-mediated expression of human lysosomal alpha-galactosidase A.
- The developmental effects of prostaglandin D2 on the pulmonary and systemic circulations in the newborn lamb.
- Plasmodium gallinaceum: mosquito peritrophic matrix and the parasite-vector compatibility.
- Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP1(19)) variants secreted from Saccharomyces cerevisiae.
- Unique specificity of in vitro inhibition of mosquito midgut trypsin-like activity correlates with in vivo inhibition of malaria parasite infectivity.
- Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1.
- Minimal variation in the transmission-blocking vaccine candidate Pfs48/45 of the human malaria parasite Plasmodium falciparum.
- A genetic locus on Plasmodium falciparum chromosome 12 linked to a defect in mosquito-infectivity and male gametogenesis.
- Human immune recognition of recombinant proteins representing discrete domains of the Plasmodium falciparum gamete surface protein, Pfs230.
- Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarose.
- Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment o...
- Meeting on Parasites and the invertebrate vector. John D and Catherine T MacArthur Foundation, November 18-21, 1993.
- Cryopreservation of Plasmodium falciparum gametocytes.
- Identification of two cysteine-rich, lipophilic proteins on the surface of Plasmodium knowlesi ookinetes: Pks20 and Pks24.
- Plasmodium: parasite chitinase and its role in malaria transmission.
- Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum.
- Cloning metabolic pathway genes by complementation in Escherichia coli. Isolation and expression of Plasmodium falciparum glucose phosphate isomerase.
- Comparison of the primary structure of the 25 kDa ookinete surface antigens of Plasmodium falciparum and Plasmodium gallinaceum reveal six conserved regions.
- Rapid method for introducing restriction sites into double stranded plasmid DNA.
- Minimal variation in a vaccine candidate from the sexual stage of Plasmodium falciparum.
- Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant Pfs25.
- Malaria transmission-blocking vaccines.
Schools
University of California At San Francisco
Doctors Specialties
- Internal Medicine
- Family Medicine
Accepted Insurances
Education
-
UCSF -
University of California San Francisco School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Marie A. Lindner, MD |
|
|
Dr. Alejandro Gonzalez, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicholas C. Battafarano, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret J. Loveland, MD |
|
Dr. John F. Spallino, MD |
|
|
Dr. Sheryl F. Talbot, MD |
|
|
Dr. Peter E. Rubin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seth J. Koss, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marlowe R. Schaeffer-Polk, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel D. Preston, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Russal Musthafa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel A. Slaim, MD |